Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Z.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
V.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.131EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.235EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.165EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.525EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.577EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.639EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.138EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.379EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.240EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.121.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-2445.63South Korea
B.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.196EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used